phenotypes, may act in concert with DSCRI, making these two molecules potentially important novel targets for therapeutic intervention in cancer." Eugenio Sangiorgi and Genomics and Genetics Faculty Member, Giovanni Neri, explains that the authors. "...used a wide range of techniques from iPS to a transgenic mo